Admission Orders for Acute Decompensated Heart Failure
Admit this patient to a telemetry unit with continuous cardiac monitoring, initiate intravenous loop diuretics (furosemide 40 mg IV bolus or equivalent to home dose if already on diuretics), supplemental oxygen to maintain SpO2 >90%, and consider non-invasive positive pressure ventilation if respiratory distress persists despite initial therapy 1.
Immediate Interventions
Respiratory Support
- Oxygen therapy: Administer supplemental oxygen ONLY if SpO2 <90% - avoid routine oxygen in non-hypoxemic patients as it causes vasoconstriction and reduces cardiac output 1
- Non-invasive positive pressure ventilation (CPAP or BiPAP): Should be considered for persistent respiratory distress to reduce work of breathing and potentially avoid intubation 1, 2
- CPAP is simpler and adequate for most cases
- BiPAP preferred if hypercapnia or COPD history present
- Caution: Monitor blood pressure closely as positive pressure ventilation can reduce BP 1
Diuretic Therapy
Initial IV furosemide dosing 1:
- If diuretic-naive: 20-40 mg IV furosemide
- If on chronic oral diuretics: Give IV dose at least equivalent to oral home dose
- Administer as intermittent boluses or continuous infusion based on response
- Monitor closely: Urine output, daily weights, renal function (BUN/Cr), electrolytes (K+, Mg2+), symptoms 1
Vasodilator Consideration
- IV vasodilators (nitroglycerin, nitroprusside) should be considered if systolic BP >90 mmHg for symptomatic relief 1
- Hold if hypotensive or systolic BP ≤90 mmHg
Diagnostic Orders
Laboratory Studies
- BNP or NT-proBNP: Essential for confirming diagnosis and establishing baseline 3, 2
- Complete metabolic panel (electrolytes, renal function, glucose)
- Complete blood count
- Troponin (rule out acute coronary syndrome)
- Thyroid function tests
- Liver function tests
- Magnesium level
Cardiac Workup
- 12-lead ECG: Assess for ischemia, arrhythmias, conduction abnormalities 3
- Echocardiogram: Determine ejection fraction (classify as HFrEF, HFmrEF, or HFpEF), assess valvular function, wall motion abnormalities 3, 2
- Continuous telemetry monitoring
Imaging
- Chest X-ray already obtained showing CHF findings
- Consider point-of-care ultrasound (POCUS) for rapid assessment of B-lines (pulmonary edema), cardiac function, and IVC diameter 4, 5
Monitoring Orders
- Vital signs: Every 4 hours minimum, more frequently if unstable
- Continuous pulse oximetry and telemetry
- Strict intake and output monitoring
- Daily weights (same scale, same time)
- Respiratory assessment: Monitor work of breathing, lung sounds every 4-8 hours
Activity and Diet
- Bed rest with head of bed elevated 30-45 degrees for comfort
- Sodium restriction: 2 grams per day
- Fluid restriction: Consider 1.5-2 liters per day if hyponatremic
- NPO until respiratory status stabilizes, then advance to cardiac diet as tolerated
Medications to Hold/Avoid
- NSAIDs: Worsen fluid retention and renal function 6
- Negative inotropes: Hold non-dihydropyridine calcium channel blockers if present
- Review and hold nephrotoxic agents if possible
Additional Considerations
Intubation Criteria
Prepare for mechanical ventilation if non-invasive measures fail and patient develops 1:
- PaO2 <60 mmHg despite oxygen therapy
- PaCO2 >50 mmHg with acidosis (pH <7.35)
- Severe respiratory fatigue or altered mental status
Common Pitfalls to Avoid
- Over-diuresis: Can precipitate cardiorenal syndrome - monitor renal function closely
- Routine oxygen in non-hypoxemic patients: Reduces cardiac output 1
- Inadequate diuretic dosing: Patients on chronic diuretics need higher initial doses due to diuretic resistance
- Ignoring blood pressure with positive pressure ventilation: Can cause significant hypotension 1
Refractory Cases
If inadequate response to loop diuretics alone, consider adding 1:
- Thiazide-type diuretic (metolazone)
- Spironolactone
- Increase to continuous infusion of loop diuretic
This structured approach prioritizes immediate stabilization of respiratory distress while establishing the diagnosis and initiating guideline-directed therapy 1.